Hatteras
Venture capitalRaleigh · Late Stage · 6 people tracked
Find your way into Hatteras
568 people in our graph share verified history with the Hatteras team — schools, employers, funds. One of them is your warm intro.
Fund manager profile
Hatteras is a venture fund manager based in Raleigh. SEC filings show 1 venture fund on record, most recently Hatteras Opportunity Fund I, LP ($125M offering) filed March 2024.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 6 people
from public directories
What they invest in
from 5 of 6 portfolio companiesBiotech ×4Healthtech ×3AI & Machine Learning ×2Medical Devices ×2Deep Tech ×1Enterprise Software ×1Fintech ×1Retail Tech ×1
HQs:United States×6
Investments · 6 tracked
founders shown can be your intro pathBy year:2025 · 12021 · 12016 · 13 dated
Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.
BiotechHealthtechMedical DevicesAlpharetta, US
Mark Prausnitz(Director)inCharles Deignan(Executive Officer)Glenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in
BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in
Board seatClay B. Thorp· per SEC Form D · $320K raise · filed Oct 2016
Co-investorsHEALTHCARE ROYALTY PARTNERSMountain Group CapitalSolasta VenturesHatteras Venture Partners
Incyclix Bio develops precision cancer treatments targeting the CDK family of enzymes to restore cell cycle control in tumors, including CDK targets beyond CDK4/6 such as CDK2.
BiotechHealthtechDurham, US
Patrick Roberts(Executive Officer and member of the Board of Managers.)in
BoardFredric N. Eshelman(Executive Officer and member of the Board of Managers.)Sid Subramony(Member of the Board of Managers.)Norman Sharpless(Member of the Board of Managers.)
Co-investorsCape Fear BioCapitalEshelman Ventures, LLCHatteras Venture Partners
Perfuse Therapeutics develops novel ocular therapies for retinal and glaucoma diseases through drug delivery and formulation platforms.
BiotechHealthtechMedical DevicesSan Francisco, US
Sevgi Gurkan, MD(Founder, Chief Executive Officer, and Member of the Board of Directors)in
BoardChristy Shaffer(Director)Chau Khuong(Director)inSevgi Gurkan(Executive Officer, Director, Promoter)in
Co-investorsOrbiMedAccess BiotechnologyCatalio Capital Management, LPHatteras Venture PartnersLAVLilly Asia Ventures
Santé builds a point-of-sale system designed specifically for liquor retail stores.
AI & Machine LearningEnterprise SoftwareFintechRetail TechSaaSNew York City, US
Darren Fike(Founder)in
Co-investorsBonfire VenturesKima VenturesOperator CollectiveTrail Run CapitalVeridical VenturesY Combinator+2 more
Ten63 develops drug-discovery technology that combines generative chemistry with quantum-accurate molecular simulation, including BEYOND (a large quantum chemistry model) and Sentinel (a virtual CSO for target selection), to design therapeutics against previously undruggable targets.
AI & Machine LearningBiotechDeep TechDurham, US
Mark A. Hallen(Executive Officer, Director)inMarcel Frenkel(Executive Officer, Director)Damien Petty(Director)inJia Wei Xu(Director)
Co-investorsCape Fear BioCapitalDFJ DragonFundDraper AssociatesDuke Capital PartnersHatteras Venture PartnersAlexandria+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesSanté · pulse2.com · Jul 19, 2026
Perfuse Therapeutics · bizjournals.com · Jun 29, 2026
Panaceutics Nutrition · chathamstartribune.com · May 15, 2026
Incyclix Bio · clinicaltrialvanguard.com · Apr 10, 2026
Clearside Biomedical · elevenflo.com · Mar 6, 2026
Frequently asked questions
- How many investments has Hatteras made?
- Hatteras has 6 tracked investments, including 1 dated in the last 24 months.
- What stage does Hatteras invest at?
- Hatteras invests at the Late Stage stage.
- Where is Hatteras located?
- Hatteras is headquartered in Raleigh, US.
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.